ArticleOpen forum infectious diseases2022

A Pilot Trial for Prevention of Hepatitis C Virus Transmission From Donor to Organ Transplant Recipient With Short-Course Glecaprevir/Pibrentasvir.

Claudia Ramirez-Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.